Literature DB >> 33359751

The role of the microbiome in diabetes mellitus.

Shili Zhang1, Yulan Cai2, Chuzhen Meng1, Xinyi Ding3, Jiali Huang1, Xiangrong Luo1, Ying Cao1, Fang Gao1, Mengchen Zou4.   

Abstract

The microbiome is greatly significant for immune system development and homeostasis. Dysbiosis in gut microbial composition and function is linked to immune responses and the development of metabolic diseases, including diabetes mellitus (DM). However, skin microbiome changes in diabetic patients and their role in DM are poorly elucidated. In this review, we summarize recent findings about the association between the gut and skin microbiota and DM, highlighting their roles in the proinflammatory status of DM. Moreover, although there is evidence that the connection between the gut and skin causes the same activated innate immune response, additional studies are needed to explore the mechanism. These findings might inform future DM prevention, diagnosis and treatment.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  diabetes mellitus; gut microbiome; skin microbiome

Mesh:

Year:  2020        PMID: 33359751     DOI: 10.1016/j.diabres.2020.108645

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  8 in total

1.  A Retrospective Analysis of Hematologic Parameters in Patients with Early Diabetic Kidney Disease.

Authors:  Xu Chen; Qinghua Wang; Chengbin Li
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389

2.  The gut microbiota composition in patients with right- and left-sided colorectal cancer and after curative colectomy, as analyzed by 16S rRNA gene amplicon sequencing.

Authors:  Daisuke Suga; Hiroki Mizutani; Shunsuke Fukui; Mayu Kobayashi; Yasuaki Shimada; Yuuichi Nakazawa; Yuuki Nishiura; Yuuya Kawasaki; Isao Moritani; Yutaka Yamanaka; Hidekazu Inoue; Eiki Ojima; Yasuhiko Mohri; Hayato Nakagawa; Kaoru Dohi; Kei Takaba; Hideo Wada; Katsuya Shiraki
Journal:  BMC Gastroenterol       Date:  2022-06-25       Impact factor: 2.847

Review 3.  Evidence Suggesting the Role of Gut Dysbiosis in Diabetic Retinopathy.

Authors:  Pratima Singh Thakur; David Aggarwal; Brijesh Takkar; Sisinthy Shivaji; Taraprasad Das
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-07-08       Impact factor: 4.925

4.  Injection site microflora in persons with diabetes: why needle reuse is not associated with increased infections?

Authors:  Sofia Wareham-Mathiassen; Lene Bay; Vera Pinto Glenting; Naireen Fatima; Henrik Bengtsson; Thomas Bjarnsholt
Journal:  APMIS       Date:  2022-05-17       Impact factor: 3.428

5.  Curcumin regulates the homeostasis of Th17/Treg and improves the composition of gut microbiota in type 2 diabetic mice with colitis.

Authors:  Qiu-Ping Xiao; You-Bao Zhong; Zeng-Ping Kang; Jia-Qi Huang; Wei-Yan Fang; Si-Yi Wei; Jian Long; Shan-Shan Li; Hai-Mei Zhao; Duan-Yong Liu
Journal:  Phytother Res       Date:  2022-03-02       Impact factor: 6.388

6.  Research progress on the mechanism by which skin macrophage dysfunction mediates chronic inflammatory injury in diabetic skin.

Authors:  Jiali Huang; Shili Zhang; Xinyi Ding; Shuxian Li; Xiangrong Luo; Ying Cao; Fang Gao; Mengchen Zou
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-24       Impact factor: 6.055

7.  Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy.

Authors:  S Ciardullo; F Zerbini; S Perra; E Muraca; R Cannistraci; M Lauriola; P Grosso; G Lattuada; G Ippoliti; A Mortara; G Manzoni; G Perseghin
Journal:  J Endocrinol Invest       Date:  2020-08-10       Impact factor: 4.256

8.  Oral Limonite Supplement Ameliorates Glucose Intolerance in Diabetic and Obese Mice.

Authors:  Akihiro Uchida; Taro Yasuma; Atsuro Takeshita; Masaaki Toda; Yuko Okano; Kota Nishihama; Corina N D'Alessandro-Gabazza; Valeria Fridman D'Alessandro; Chisa Inoue; Takehiro Takagi; Hiroyuki Mukaiyama; Norio Takagi; Katsumi Shimizu; Yutaka Yano; Esteban C Gabazza
Journal:  J Inflamm Res       Date:  2021-07-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.